THRX NASDAQ
Theseus Pharmaceuticals, Inc.
1W: +0.0%
1M: +1.5%
3M: +20.5%
1Y: -59.9%
$4.07
Last traded 2024-02-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-56M
Net Income
-27.4% YoY
$-50M
Free Cash Flow
-49.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-25.2%
ROA-24.0%
ROIC-227.9%
Valuation
P/E-3.3
P/B0.8
EV/EBITDA1.3
Leverage
Debt/Equity0.02
Current Ratio29.93
Interest Cov.-36.7x
Quality Scores
Piotroski F3/9
Altman Z6.22
Beneish M0.00